Plandaí Biotechnology, Inc. (PLPL)

0.0004 0.0000 (0.00%) At close: 03:59PM EDT

Plandaí Biotechnology, Inc.

17 Hanover Square
London W1S 1BN
United Kingdom
44 91 7900 9829
https://www.plandaibiotech.com

Sector(s): Financial Services
Industry: Shell Companies
Full-time employees: 180

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Roger Baylis-Duffield	Co-Founder, Chairman and Chief Executive Officer	180k	N/A	1943
Mr. Callum Baylis-Duffield	President, Chief Operating Officer and Director	120k	N/A	1985
Mr. Ezra Jones	Vice President of Sales and Marketing	N/A	N/A	N/A

Amounts are as of 31 December 2016, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.

Corporate governance

Plandaí Biotechnology, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.